— Know what they know.
Not Investment Advice

CPRX NASDAQ

Catalyst Pharmaceuticals, Inc.
1W: +0.4% 1M: +20.6% 3M: +28.7% YTD: +35.1% 1Y: +26.7% 3Y: +150.0% 5Y: +467.7%
$31.26
-0.02 (-0.06%)
 
Weekly Expected Move ±6.4%
$27 $29 $31 $33 $35
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 68 · $3.8B mcap · 116M float · 1.73% daily turnover · Short 57% of daily vol

📊 Key Metrics

TTM
$597M
Revenue
+11.7% YoY
$221M
Net Income
+12.1% YoY
$208M
Free Cash Flow
-22.2% YoY
83.8%
Gross Margin
49.0%
Op. Margin
42.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE26.3%
ROA22.6%
ROIC80.6%

Valuation

P/E17.3
P/B3.8
EV/EBITDA7.8

Leverage

Debt/Equity0.00
Current Ratio6.08
Interest Cov.0.0x

Quality Scores

Piotroski F5/9
Altman Z15.13
Beneish M-1.60

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms